SLC25A22 DRIVES IMMUNE SUPPRESSION IN KRAS-MUTANT COLORECTAL CANCER VIA METABOLIC REGULATION OF CXCL1/CXCR2 AXIS

被引:0
|
作者
Zhou, Qiming
Peng, Yao
Chan, Lam-Shing
Chen, Huarong
Kang, Wei
Nie, Yuqiang
Yu, Jun
Wong, Chi Chun
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su111
引用
收藏
页码:S621 / S621
页数:1
相关论文
共 24 条
  • [21] Up-regulation of CXCL1 and CXCR2 contributes to remifentanil-induced hypernociception via modulating spinal NMDA receptor expression and phosphorylation in rats
    Yang, Li-hua
    Xu, Guang-min
    Wang, Yu
    NEUROSCIENCE LETTERS, 2016, 626 : 135 - 141
  • [22] METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer
    Chen, Huarong
    Pan, Yasi
    Zhou, Qiming
    Liang, Cong
    Wong, Chi-Chun
    Zhou, Yunfei
    Huang, Dan
    Liu, Weixin
    Zhai, Jianning
    Gou, Hongyan
    Su, Hao
    Zhang, Xiaoting
    Xu, Hongzhi
    Wang, Yifei
    Kang, Wei
    Wu, William Ka Kei
    Yu, Jun
    GASTROENTEROLOGY, 2022, 163 (04) : 891 - 907
  • [23] Concomitant NAFLD Facilitates Liver Metastases and PD-1Refractory by Recruiting MDSCs via CXCL5/CXCR2 in Colorectal Cancer
    Yang, Yue
    Chen, Yunsong
    Liu, Zhaogang
    Chang, Zhibin
    Sun, Zhicheng
    Zhao, Lei
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2024, 18 (02):
  • [24] KRAS-TP53 cooperativity regulates Cxcl1 to sustain tumor-permissive circuitry via granulocyte-derived CXCR2-TNF signaling in pancreatic cancer.
    Bianchi, Anna
    Silva, Iago De Castro
    Deshpande, Nilesh U.
    Mehra, Siddharth
    Garrido, Vanessa T.
    Singh, Samara
    Rafie, Christine I.
    Zhou Zhiqun
    Ogobuiro, Ifeanyichukwu C.
    Dosch, Austin R.
    Nagathihalli, Nagaraj
    Merchant, Nipun B.
    Datta, Jashodeep
    CANCER RESEARCH, 2022, 82 (22) : 132 - 133